Nu-Med Plus, Inc. appointed Keith L. Merrell as a Chief Financial Officer replacing Mark Christensen. Mr. Merrell brings over 30 years of business and accounting experience while serving as Chief Financial Officer or Controller of five companies both public and private, and correspondingly he has had numerous years of involvement with SEC reporting during his professional tenure. His business career also includes extensive experience in mergers and acquisitions.
On July 28, 2015, the company received the resignation of Mark Christensen from his position as Chief Financial Officer due to other commitments which would no longer allow him to devote the time needed for the Company. Mr. Christensen has no disputes with the Company and will continue to help with the financial statements during the transition to new CFO.
Nu-Med Plus, Inc. is a medical device company, which is principally engaged in the designing, development, enhancement and commercialization of later-stage medical devices. The Company is focused on the creation of a nitric oxide generating formulation, a hospital bedside nitric oxide (NO) delivery system, a clinical unit for use in medical clinics and rehabilitation centers and a mobile rechargeable device to deliver nitric oxide gas to offer solutions to hospitals, health systems and the medical community throughout the world. Hospital NO Unit delivers a continuous intra-breath concentration of therapeutic NO to patients who are on a ventilator in a hospital setting. Clinical Delivery System is a simplified version of the hospital unit. Portable Delivery System delivers high purity NO to the patient at prescribed intervals for 24 hours per day at controlled doses by means of a nasal cannula or a face mask. Reagent Delivery provides a range of concentrations and flow rates of NO.
NU-MED PLUS, INC. 
